Jonathann Kuo, MD
MD: Boston University
Residency: New York Presbyterian Hospital / Weill Cornell
Fellowship: New York Presbyterian Hospital / Hospital for Special Surgery / Memorial Sloan Kettering Cancer Center
Founder, CEO, & Medical Director, Pain Medicine
With a track record of over 30,000 spinal and joint procedures, Dr. Kuo is a highly skilled and seasoned interventionist. His expertise extends to the precise injection of various body parts, including joints, tendons, cartilage, nerves, and intervertebral discs, all guided by X-ray and ultrasound imaging. The integration of regenerative medicine products, like exosomes, concentrated platelet-rich plasma, and peptides has ushered in a groundbreaking era in regenerative medicine. This innovative approach empowers patients to stimulate their body's natural healing processes without the necessity for surgical interventions.
Dr. Kuo actively contributes to clinical research that evaluates the newest biologics and their applications in degenerative spinal and joint and systemic inflammatory conditions. He has traveled extensively to leading laboratories to collaborate with global thought leaders in the regenerative field.
More about Dr. Kuo
Areas of Interest
IV Exosomes Overview
"With regenerative therapeutics gaining the attention of researchers and clinicians across the world, exosomes have been widely recognized as a potential treatment avenue for a range of degenerative conditions and diseases."Learn More →
"Nicotinamide adenine dinucleotide (NAD) is well-known as an electron carrier in redox reactions and has recently been studied extensively due to emerging knowledge about its role in intracellular signaling pathways."Learn More →
Bone Marrow Aspirate Concentrate
"The unique regenerative properties of BMAC provide evidence for its use in the treatment of musculoskeletal conditions such as OA, tendinopathy, and spinal conditions."Learn More →
"In recent years, regenerative medicine therapies using biologic applications, such as stem cell products and platelet-rich plasma treatments, have gained the attention of many researchers and clinicians due to encouraging experimental evidence."Learn More →